RSS   Newsletter   Contact   Advertise with us
Post Online Media

Paratek Pharmaceutical appoints Rolf K. Hoffman to board

Rolf K HoffmanParatek Pharmaceutical, a biopharmaceutical company, announced the appointment of Rolf K. Hoffman to the company’s board of directors.

Mr. Hoffman brings significant experience in pharmaceutical commercial strategy and operations to the Paratek board, having served in several senior commercial management roles over the course of his career.

Most recently, Mr. Hoffman spent 12 years at Amgen, including as Senior Vice President, International Commercial Operations and Senior Vice President, U.S. Commercial Operations.

Prior to that, he held several senior global roles at Eli Lilly and Company including President, Latin America and General Manager in Germany and South Africa.

Mr. Hoffman is currently Chairman of Biotest AG, serves on the Board of Directors of Europe’s largest biotechnology company Genmab AG, and is a Director of San Francisco-based Trigemina, Inc.

He was also recently appointed to the board of specialty pharmaceutical company EUSA Pharma.

In addition, Mr. Hoffman is an adjunct professor for Strategy and Entrepreneurship at the University of North Carolina at Chapel Hill where he earned his Master’s in Business Administration.


 LATEST MOVES FROM Massachusetts 


POST Online Media does not use cookies to collect information about visitors.   OK, hide this message   Third party ads may be using cookies, you can see how here.